Comparison between Dexamedetomidine versus Labetalol for controlled Hypotensive Technique in Functional Endoscopic sinus Surgery : A randomized Controlled Trial

Status

Active, not recruiting

Phases

Phase 4

Study type

Interventional

Source

PACTR

Registry ID

PACTR202511738071134

Enrollment

Registered

2025-11-21

Start date

2025-11-01

Completion date

Unknown

Last updated

2026-09-14

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Anaesthesia

Interventions

Labetalol

Dexmedetomidine

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: - ASA physical status I–II - Age 18 –65 years -male and female - Scheduled for elective FESS - Consent to participate

Exclusion criteria

Exclusion criteria: ASA III or higher - Allergy to study drugs - Bradycardia, heart block, asthma - Chronic use of beta-blockers or a2-agonists - Coagulopathy or bleeding disorders -Acute decompensated heart failure - Peripheral vascular disease

Design outcomes

Primary

Measure	Time frame
Hemodynamics SBP, MAP,HR	—

Secondary

Measure	Time frame
Total blood loss (mL	—

Countries

Egypt

Contacts

Public ContactMohamed Hany Galal Galal

Anesthesia ICU and pain mangement assiut university

Mohamed.17289660@med.aun.edu.eg+201001620542

Outcome results

None listed

Source: PACTR (via WHO ICTRP) · Data processed: Sep 19, 2026